{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:23:12Z","timestamp":1791937392414,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600572"],"award-info":[{"award-number":["81600572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Development Program","award":["20170520025JH"],"award-info":[{"award-number":["20170520025JH"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.peptides.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T16:27:29Z","timestamp":1554481649000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K\/Akt\/mTOR pathway"],"prefix":"10.1016","volume":"114","author":[{"given":"Yixian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7358-7637","authenticated-orcid":false,"given":"Lining","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (3)","key":"10.1016\/j.peptides.2019.04.005_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"January (1)","key":"10.1016\/j.peptides.2019.04.005_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"June (6)","key":"10.1016\/j.peptides.2019.04.005_bib0015","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.04.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/948417","article-title":"Inflammatory cytokines in diabetic nephropathy","volume":"2015","author":"Donate-Correa","year":"2015","journal-title":"J. Diabetes Res."},{"issue":"February (2)","key":"10.1016\/j.peptides.2019.04.005_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ki.1987.50","article-title":"Microalbuminuria as a predictor of clinical diabetic nephropathy","volume":"31","author":"Mogensen","year":"1987","journal-title":"Kidney Int."},{"issue":"April (4)","key":"10.1016\/j.peptides.2019.04.005_bib0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ki.1992.126","article-title":"Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study","volume":"41","author":"Rudberg","year":"1992","journal-title":"Kidney Int."},{"issue":"January (2)","key":"10.1016\/j.peptides.2019.04.005_bib0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"Pagtalunan","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"January (1)","key":"10.1016\/j.peptides.2019.04.005_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"Pavenstadt","year":"2003","journal-title":"Physiol. Rev."},{"issue":"January (1)","key":"10.1016\/j.peptides.2019.04.005_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9440(10)64357-X","article-title":"Podocin localizes in the kidney to the slit diaphragm area","volume":"160","author":"Roselli","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"October (1)","key":"10.1016\/j.peptides.2019.04.005_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.139.1.193","article-title":"Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes","volume":"139","author":"Mundel","year":"1997","journal-title":"J. Cell Biol."},{"issue":"January (2)","key":"10.1016\/j.peptides.2019.04.005_bib0055","doi-asserted-by":"crossref","first-page":"F205","DOI":"10.1152\/ajprenal.90005.2013","article-title":"Interplay between the Notch and PI3K\/Akt pathways in high glucose-induced podocyte apoptosis","volume":"306","author":"Wang","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.peptides.2019.04.005_bib0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/10799893.2015.1101137","article-title":"CD2-associated protein participates in podocyte apoptosis via PI3K\/Akt signaling pathway","volume":"36","author":"Ren","year":"2016","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"January (3)","key":"10.1016\/j.peptides.2019.04.005_bib0065","first-page":"98","article-title":"Protein kinase B\/Akt regulation in diabetic kidney disease","author":"Heljic","year":"2011","journal-title":"Front. Biosci. (Schol Ed)"},{"issue":"January (1)","key":"10.1016\/j.peptides.2019.04.005_bib0070","doi-asserted-by":"crossref","first-page":"F49","DOI":"10.1152\/ajprenal.00032.2009","article-title":"Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy","volume":"298","author":"Rane","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"September (9)","key":"10.1016\/j.peptides.2019.04.005_bib0075","first-page":"e152","article-title":"Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells","volume":"37","author":"Zhou","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.peptides.2019.04.005_bib0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000106782","article-title":"Rapamycin prevents early steps of the development of diabetic nephropathy in rats","volume":"27","author":"Yang","year":"2007","journal-title":"Am. J. Nephrol."},{"issue":"December (6)","key":"10.1016\/j.peptides.2019.04.005_bib0085","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev. Cell"},{"issue":"February (6172)","key":"10.1016\/j.peptides.2019.04.005_bib0090","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science."},{"issue":"October (1-3)","key":"10.1016\/j.peptides.2019.04.005_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.regpep.2012.06.006","article-title":"Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats","volume":"178","author":"Najafipour","year":"2012","journal-title":"Regul. Pept."},{"issue":"July (30)","key":"10.1016\/j.peptides.2019.04.005_bib0100","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1074\/jbc.M115.648238","article-title":"Apela regulates fluid homeostasis by binding to the APJ receptor to activate gi signaling","volume":"290","author":"Deng","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"October (4)","key":"10.1016\/j.peptides.2019.04.005_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.stem.2015.08.010","article-title":"ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K\/AKT pathway","volume":"17","author":"Ho","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"March (12)","key":"10.1016\/j.peptides.2019.04.005_bib0110","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.peptides.2019.04.005_bib0115","first-page":"1","article-title":"Streptozotocin\u2010induced diabetic models in mice and rats. Current protocols in pharmacology","volume":"70:5.47","author":"Furman","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"10","key":"10.1016\/j.peptides.2019.04.005_bib0120","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/jcbfm.2013.130","article-title":"Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus","volume":"33","author":"Jouihan","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"August (2)","key":"10.1016\/j.peptides.2019.04.005_bib0125","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3892\/mmr.2016.5441","article-title":"GSK-3beta inhibitor attenuates urinary albumin excretion in type 2 diabetic db\/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes","volume":"14","author":"Wan","year":"2016","journal-title":"Mol Med Rep."},{"issue":"4","key":"10.1016\/j.peptides.2019.04.005_bib0130","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1159\/000479212","article-title":"Crocin protects podocytes against oxidative stress and inflammation induced by high glucose through inhibition of NF-kappaB","volume":"42","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem."},{"issue":"June (6)","key":"10.1016\/j.peptides.2019.04.005_bib0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonzalez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"March (3)","key":"10.1016\/j.peptides.2019.04.005_bib0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonzalez","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"December (6)","key":"10.1016\/j.peptides.2019.04.005_bib0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2006.09.011","article-title":"The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications","volume":"17","author":"Navarro","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"January (1)","key":"10.1016\/j.peptides.2019.04.005_bib0150","doi-asserted-by":"crossref","first-page":"F113","DOI":"10.1152\/ajprenal.00026.2002","article-title":"Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes","volume":"284","author":"DiPetrillo","year":"2003","journal-title":"Am. J. Physiol Renal Physiol."},{"issue":"July (30)","key":"10.1016\/j.peptides.2019.04.005_bib0155","doi-asserted-by":"crossref","first-page":"47760","DOI":"10.18632\/oncotarget.10283","article-title":"MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARgamma pathway in diabetic nephropathy","volume":"7","author":"Hou","year":"2016","journal-title":"Oncotarget"},{"issue":"October (9)","key":"10.1016\/j.peptides.2019.04.005_bib0160","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/0886022X.2016.1227918","article-title":"Protective effect of L-glutamine against diabetes-induced nephropathy in experimental animal: role of KIM-1, NGAL, TGF-beta1, and collagen-1","volume":"38","author":"Sadar","year":"2016","journal-title":"Ren Fail."},{"issue":"November (3)","key":"10.1016\/j.peptides.2019.04.005_bib0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2018.09.175","article-title":"Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K\/Akt signaling pathway","volume":"506","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"August (1)","key":"10.1016\/j.peptides.2019.04.005_bib0170","doi-asserted-by":"crossref","first-page":"13011","DOI":"10.1038\/s41598-018-31464-9","article-title":"An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury","volume":"8","author":"Fujita","year":"2018","journal-title":"Sci. Rep."},{"issue":"September","key":"10.1016\/j.peptides.2019.04.005_bib0175","first-page":"6","article-title":"Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1\/PGC-1alpha mediated attenuation of mitochondrial oxidative stress","author":"Zhang","year":"2018","journal-title":"J. Cell Physiol."},{"issue":"July (14)","key":"10.1016\/j.peptides.2019.04.005_bib0180","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1128\/MCB.23.14.4917-4928.2003","article-title":"Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling","volume":"23","author":"Huber","year":"2003","journal-title":"Mol. Cell Biol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119300361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119300361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:23:55Z","timestamp":1759310635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119300361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":36,"alternative-id":["S0196978119300361"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.04.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K\/Akt\/mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}